Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

biOasis Technologies Ord Shs V.BTI.H

Alternate Symbol(s):  BIOAF

Bioasis Technologies Inc. is a Canada-based biopharmaceutical company focused on research and development of technologies and products intended for the treatment of patients with nervous system, including central nervous system, diseases and disorders. The Company is engaged in the development of its xB 3 platform, which is a peptide-based technology, for the transport of therapeutic agents, in particular biological products, across the blood-brain barrier (BBB). It is focused on both orphan drug indications, including brain cancers, and rare genetic neurodegenerative diseases and neuroinflammatory conditions. The Company is also focused on its Epidermal Growth Factor (EGF) platform for treating rare and orphan neurodegenerative and neuroinflammatory disorders. EGF is a protein that stimulates cell growth and differentiation, notably for myelin producing cells. Its development programs include xB3-001: Brain Metastases, xB3-002: Glioblastoma and xB3-007: Neurodegenerative Disease.


TSXV:BTI.H - Post by User

Comment by Sniper007on Mar 27, 2014 5:43pm
181 Views
Post# 22378719

RE:RE:RE:RE:RE:Good news but...

RE:RE:RE:RE:RE:Good news but...
"I have always felt, Sniper007, that, you know, there's stuff I don't know, that I shouldn't complain about stuff that may be well in hand behnd the scenes. The company knows stuff we don't know." 
Yes, that is the frustrating part, not knowing.  Today I'm just particularily frustrated and your post set me off; mostly because we "don't know".  I feel, somehow, that BTI has some kind of masterplan that will play out when they want it to (I know you are not of that opinion JD); maybe that's just blind faith but all indicators point to something incredible happening with BTI.  My frustration originally started to brew with the market not acknologing the Feb. 7, 2013 NR and it is still not given much of a value to BTI even with the last 3 NR's.  It's the pharma, yes, that will make this thing move, it's just so frustrating watching it do nothing because there is "nothing" to report that will make the market move.  That said, we've had some good reawlly news lately.  Hopefully more to come.  I believe in this company too, just anxious and frustrated.  Go BTI.
Sniper
Bullboard Posts